Year in Review 2024 - Transformative FDA Approvals in Precision Onco…

Oncology 2024 Year in Review

V. Subbiah

Colorectal Cancer Epidemiology and Screening in 2025

UCSF School of Medicine

S. Gupta

Early-Onset CRC: Epidemiology, Risk Factors, and Clinical Presentati…

Ibrahim Sahin

GI Cancers: Hot Topics in 2024

Yale Cancer Center

J. Lacy

48 Hours in the Life of Receiving a Diagnostic Colonoscopy

UCI Health

A. Dua

Year in Review 2024 - Colorectal Cancer

Oncology 2024 Year in Review

R. Kim, T. Biachi

ESMO 2024 Summary: Late-Line Therapy in mCRC - How to Choose

2024 ESMO Annual Meeting Insights Hub

H. Hochster

ASCO® GI 2025 Insights: Ph3 BREAKWATER Study - Encorafenib + Cetuxim…

Insights from 2025 ASCO® GI Annual Meeting

S. Kopetz

Cancer Screening in Primary Care: An Evidence-Based Review of Outpat…

UNC Lineberger Comprehensive Cancer Center

N. Robertson

ASCO® GI 2025 Insights: CheckMate 8HW - First Results of Nivo + Ipi …

Insights from 2025 ASCO® GI Annual Meeting

T. André

ESMO 2024 Summary: Neoadjuvant Colon Cancer Treatment - Recent Clini…

2024 ESMO Annual Meeting Insights Hub

J. Taieb

Surveillance Imaging in Solid Tumors: More Complicated Than It Appea…

ecancer

C. Booth

ASCO® GI 2025 Insights: Trifluridine/Tipiracil vs. Placebo in Patien…

Insights from 2025 ASCO® GI Annual Meeting

H. Bando

Rising Trends of Colorectal Cancer Among Millennials

Dr. Iris Gorfinkel

I. Gorfinkel

Anal Cancer: Risk Factors and Prevention

GRACE

P. Romesser

ESMO 2024 Summary: The Emerging Global Epidemic of Early-Onset Cance…

2024 ESMO Annual Meeting Insights Hub

S. Ogino

The Importance of 1L Biomarkers in CRC

Nicholas DeVito

ASCO® GI 2025 Insights: Encorafenib + Cetuximab +/- Binimetinib in B…

Insights from 2025 ASCO® GI Annual Meeting

Y. Sunakawa

ASCO® GI 2025 Insights: Uses of Bevacizumab in Appendiceal Adenocarc…

Insights from 2025 ASCO® GI Annual Meeting

J. Shen

ESMO 2024 Summary: Highlights in CRC and Impacts on Practice

2024 ESMO Annual Meeting Insights Hub

R. Kim, T. Biachi